<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib45">
 <element-citation publication-type="journal" id="sref45">
  <person-group person-group-type="author">
   <name>
    <surname>Pottecher</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Noll</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Borel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Audibert</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Gette</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Gaertner</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Legros</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Carapito</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Uring-Lambert</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients</article-title>
  <source>Trials</source>
  <volume>21</volume>
  <year>2020</year>
  <fpage>1</fpage>
  <lpage>13</lpage>
  <pub-id pub-id-type="pmid">31898511</pub-id>
 </element-citation>
</ref>
